Applicability of animal tumor data to cancer therapy in humans

International Journal of Radiation Oncology, Biology, Physics

Volumn 14, Issue 5, 1988, Pages 913-927

  Moulder, John E ^a   Dutreix, Jean ^b   Rockwell, Sara ^c   Siemann, Dietmar W ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Animals; Fractionation; Heterogeneity; Oxygenation; Radiobiology; Radiotherapy; Tumors

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; LOMUSTINE; MISONIDAZOLE;

ANIMAL MODEL; CANCER RADIOTHERAPY; HUMAN; HYPOXIA; NONHUMAN; RADIATION DOSE FRACTIONATION;

ANIMAL; ANOXIA; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMAN; MICE; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RADIOTHERAPY DOSAGE; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023877092     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(88)90014-4     Document Type: Article

References (135)

1. Electron-affinic sensitization: VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers
2. Potentially lethal damage (PLD) repair in human epidermoid tumor cells grown in vivo and in vitro
3. Analysis and sorting of living cells according to deoxyribonucleic acid content
4. Variations in radiation response among experimental tumors
5. Dose fractionation, dose rate and isoeffect relationships for normal tissue response
6. Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays. II. Effects of fractionated treatments applied five times a week for several weeks
7. Dangers of the clinical use of the NSD formula for small fraction numbers
8. Isolation of quiescent cells from multicellular tumor spheroids using centrifugal elutriation
9. The effect of hypoxia on the growth and radiation response of mammalian cells in culture
10. Excess late subcutaneous fibrosis after irradiation of pig skin consequent upon the application of the NSD formula
11. The effect of prolonged hypoxia on growth and viability of Chinese hamster cells
12. Drug or radiation changes to the host which could affect the outcome of combined modality therapy
13. Evidence for acutely hypoxic cells in mouse tumors, and a possible mechanism of reoxygenation
14. Clinical trials of radiosensitizers: What should we expect?
15. Biological discussions augmenting radiation effects and model systems
16. Definitive evidence for hypoxic cells influencing cure in cancer therapy
17. Cell selection from a murine tumor using the fluorescent probe Hoechst 33342
18. Intermittent blood flow in a murine tumor: Radiobiological effects
19. A marker for hypoxic cells in tumours with potential clinical applicability
20. The radioresponsiveness of human tumours and the initial slope of the cell survival curve
21. Experimental tumor systems: Standardization of endpoints
22. In vitro systems: standardization of endpoints
23. Concurrent cis-diamminedichloroplatinum (II) and radiation treatment for melanoma metastases: A pilot study
24. Hyperbaric oxygen: the Medical Research Council trials and their clinical significance
25. Chemical sensitizers for hypoxic cells: A decade of experience in clinical radiotherapy
26. The effect of multiple small doses of X-rays on skin reactions in the mouse and a basic interpretation
27. Effects of intercellular contact on repair of radiation damage
28. Cell survival curves deduced from non-quantitative reactions of skin, intestinal mucosa and lung
29. Cellular recovery in human skin reactions: Application to dose fraction number overall time relationship in radiotherapy
30. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy
31. Effects of fractionated radiation in mouse lung and a phenomenon of slow repair
32. Perfluorochemicals and hyperbaric oxygen in radiation therapy
33. The interplay of radiocurability and tolerance in the irradiation of human cancers
34. Radiation sciences and medical radiology
35. Total doses in fractionated radiotherapy—Implications of new radiobiological data
36. What next in fractionated radiotherapy?
37. Chemical modifiers of radiosensitivity—therapy and reality: A review
38. A review of hypoxic cell radiosensitization in experimental tumors
39. Skin reactions in mice after multifraction X-irradiation
40. Misonidazole and other hypoxia markers: Metabolism and applications
41. Radiobiological basis of oxygen as a modifying factor in radiation therapy
42. The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy
43. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion
44. Experimental data on the radiobiology of solid tumors
45. Augmentation of adriamycin, melphalan, and cis-platinum cytotoxicity in drug resistant and sensitive human ovarian carcinoma cell lines by buthione sulfoxomine mediated glutathione depletion
46. Induction characteristics of oxygen regulated proteins
47. A critique of the evidence of host defense against cancer based on personal studies of 27 murine tumours of spontaneous origin
48. Sensitizers and radiation dose fractionation: Results and interpretations
49. Unequivocal clinical evidence for the oxygen effect
50. Oxygen delivery to tumors
51. The phenomenon of reoxygenation and its implications for fractionated radiotherapy
52. Separation of malignant cells from host cells using centrifugal elutriation
53. Comparison of tumour age response to radiation for cells derived from tissue culture or solid tumours
54. Direct synchronization of cells from solid tumors by centrifugal elutriation
55. The hypoxic tumor cell: A target for selective cancer chemotherapy
56. The effect of extreme hypoxia and glucose of the repair of potentially lethal and sublethal radiation damage by mammalian cells
57. Reoxygenierung in einem transplantablen Fibrosarkom der Maus
58. Fatal misonidazole-induced encephelopathy
59. Glutathione as a determinant of cellular response to adriamycin
60. Tumor volume, dose fractionation and repopulation in the response of oral cavity and oropharynx cancers to radiotherapy
61. The relationship between growth rate, labelling index and histological type of human solid tumours
62. Distribution of radiation sensitivities for human tumors cells of specific histological types: comparison of in vitro to in vivo data
63. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen
64. The effect of repeated small doses of radiation on recovery from sublethal damage by Chinese hamster cells irradiated in oxic or hypoxic conditions
65. The effect of repeated small doses of radiation on recovery from sublethal damage by Chinese hamster cells irradiated in the plateau phase of growth
66. A factor of importance in the radiosensitivity of tumours
67. Radiation reaction of rat skin: The role of the number of fractions and the overall treatment time
68. Dependence of misonidazole radiosensitization on drug and radiation schedules
69. Effect of total body irradiation with bone marrow transplantation on the toxicity of cis-platinum
70. Tumor sensitization by the intermittent use of perfluorochemical emulsions and carbogen breathing in fractionated radiotherapy
71. Renal irradiation and the pharmacology and toxicity of methotrexate and cisplatinum
72. Hypoxic fractions of solid tumors
73. Comparison of tumor assay methods
74. Tumor hypoxia: Its impact on cancer therapy
75. Multiple small fractions per day versus conventional fractionation. Comparison of normal tissue reactions and effect on breast carcinoma
76. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumors
77. Fluorescent nitroheterocycles for identifying hypoxic cells
78. Some factors of importance in the radiation treatment of malignant melanomas
79. Reduced oxygen enhancement ratio at low doses of ionizing radiation
80. 2 + M phases after irradiation of a solid tumor in vivo
81. Cell kinetics of irradiated experimental tumors: Cell transition from the non-proliferating to the proliferating pool
82. A multicomponent X-ray survival curve for mouse lymphosarcoma cells irradiated in vivo
83. The oxygen effect in radiation inactivation of DNA and enzymes
84. Partial hypoxia as a cause of radioresistance in a human tumor xenograft: Its influence illustrated by the sensitizing effect of misonidazole and hyperbaric oxygen
85. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells
86. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion
87. Biological factors of importance in split-course radiotherapy
88. Human tumour xenografts in radiotherapeutic research
89. Enhanced cytotoxicity of anti-neoplastic agents following prolonged exposure to misonidazole
90. A clinical trial of Fluosol-DA 20% in advanced squamous cell carcinoma of the head and neck
91. Reoxygenation after a single dose of 15 Gy in the EMT6/KU sarcoma
92. Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites
93. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-irradiation and hypoxic cell radiosensitizers
94. Modification of chemotherapy by nitroimidazoles
95. Increased therapeutic benefit through the addition of misonidazole to a nitrosourea-radiation combination
96. In situ radiation response and oxygen enhancement ratio of KHT sarcoma cells in various phases of cell cycle
97. Cell cycle specific toxicity of the Hoechst 33342 stain in untreated or irradiated murine tumor cells
98. Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. I. Centrifugal elutriation
99. Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation
100. Tumor radiosensitization through reductions in hemoglobin affinity
101. In vivo interaction between radiation and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice
102. Cellular and molecular repair of x-ray induced damage: Dependence on oxygen tension and nutritional status
103. Cell killing, radiosensitization and cell cycle redistribution induced by chronic hypoxia
104. Cell loss as a factor in the growth rate of human tumours
105. Radiation-induced renal damage: The effects of hyperfractionation
106. 3H mammary carcinoma to fractionated irradiation on fraction number and intertreatment interval
107. Immunologic status of host and response of a methylcholanthrene induced sarcoma by local X-irradiation
108. Radiation dose fractionation and tumor control probability
109. Resistance to adriamycin in multicellular spheroids
110. On the nature of the radiobiologically hypoxic fraction in tumors
111. Potentials and limitations for the use of radiation sensitizers of resistant hypoxic cells in tumors
112. The Response of Viable Tumor Cords to a Single Dose of Radiation
113. Oxygen diffusion and the distribution of cellular radiosensitivity in tumours
114. Perfluorochemical emulsions can increase tumor radiosensitivity
115. Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
116. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
117. Cell-cycle distributions and radiation responses of Chinese hamster cells cultured continuously under hypoxic conditions
118. Dose response curve and split dose recovery in human skin cancer
119. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia
120. Effects of X-rays and neutrons on repair and regeneration in the rat spinal cord
121. Analysis of cell survival after multiple fractions per day and low dose rate irradiation of two in vitro cultured rat tumor cell lines
122. Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors
123. Radiation pneumonitis: a new approach to the derivation of time dose factors
124. Radiosensitization of Chinese hamster cells by oxygen and misonidazole at low x-ray doses
125. Radiation damage to the rat spinal cord: the effect of single and fractionated doses of X-rays
126. A review of α/β ratios for experimental tumors: implications for clinical studies of altered fractionation
127. Biological basis for high-LET radiotherapy
128. The relationship of acute to late skin injury in 2 and 5 fraction/week X-ray therapy
129. Differences in the fractionation response of acutely and late responding tissues
130. 3H 10T1/2